Pfizer’s Diabetes Pill Shows Similar Weight Loss Results As Ozempic
View Source | May 24, 2023 5:00 am
- Pfizer’s oral diabetes drug demonstrated promising weight loss that some experts say could work just as fast as Novo Nordisk’s highly sought after Ozempic.
- In the mid-stage trial, over 400 adults with Type 2 diabetes took Pfizer’s danuglipron twice a day or a placebo pill for roughly four months to test its efficacy.
- The results showed that every dose of the danuglipron pill reduced patients’ blood sugar at week 16 compared to the placebo.
Click to read full article
Share This Article: